RxDoctor Payments Data

Benjamin Eliason, MD

Psychiatry · South Jordan, UTNPI 1659418267

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.7% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 26.0% of the total. Reporting peaked in 2019 at $358 and has fallen 74.2% since, to $92 in 2025.

$1,486in general payments, 2019–2025

Across 98 payments — averaging $15.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$386
  • Otsuka America Pharmaceutical, Inc.$268
  • Johnson & Johnson$167
  • Neurocrine Biosciences, Inc.$142
  • Alkermes, Inc.$130
  • Sunovion Pharmaceuticals Inc.$77
  • plus $316 from 10 others

What the payments were for

  • Food & beverage$1,43797%
  • Education$493%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,486 in reported general payments places this provider in the 85th percentile of 231 psychiatry providers in Utah.

See all psychiatry providers in Utah

Medicare billing

Part B allowed, 2024
$25,422
Medicare patients
25
Services billed
244

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trazodone Hcl34$964
Duloxetine Hcl29$881
Sertraline Hcl53$837
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine28$660
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine16$642
Lorazepam51$602
Bupropion XlBupropion Hcl23$595
Prazosin Hcl24$557
Buspirone Hcl24$538
Quetiapine Fumarate28$416
Topiramate14$372
Gabapentin19$332
Clonazepam32$308
Citalopram HbrCitalopram Hydrobromide13$283
Venlafaxine Hcl ErVenlafaxine Hcl18$242

Paid to pharmacies, not to this prescriber.

Other psychiatry in South Jordan

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →